Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P McEvoy

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Psychiatry|December 19, 2019
FDA-Approved Medications to Treat Tardive DyskinesiaJoseph P McEvoy
JAMA Psychiatry|July 21, 2016
Use of Clozapine in SchizophreniaJoseph P McEvoy
CNS Spectrums|July 4, 2006
An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studyJoseph P McEvoy
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|March 19, 2009
Much ado about small differencesJoseph P McEvoy
The Journal of Clinical Psychiatry|February 26, 2008
The costs of schizophreniaJoseph P McEvoy
The Journal of Clinical Psychiatry|June 27, 2008
Functional outcomes in schizophreniaJoseph P McEvoy
The Journal of Clinical Psychiatry|November 4, 2020
How to Assess Tardive Dyskinesia Symptom Improvement With Measurement-Based CareJoseph P McEvoy
The Journal of Clinical Psychiatry|March 6, 2018
Evidence-Based Strategies for Managing Tardive DyskinesiaJoseph P McEvoy
Behavioral Healthcare|June 1, 2007
The importance of early treatment of schizophreniaJoseph P McEvoy
The Journal of Clinical Psychiatry|July 11, 2006
Risks versus benefits of different types of long-acting injectable antipsychoticsJoseph P McEvoy
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Psychiatry|December 19, 2019
FDA-Approved Medications to Treat Tardive DyskinesiaJoseph P McEvoy
JAMA Psychiatry|July 21, 2016
Use of Clozapine in SchizophreniaJoseph P McEvoy
CNS Spectrums|July 4, 2006
An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studyJoseph P McEvoy
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|March 19, 2009
Much ado about small differencesJoseph P McEvoy
The Journal of Clinical Psychiatry|February 26, 2008
The costs of schizophreniaJoseph P McEvoy
The Journal of Clinical Psychiatry|June 27, 2008
Functional outcomes in schizophreniaJoseph P McEvoy
The Journal of Clinical Psychiatry|November 4, 2020
How to Assess Tardive Dyskinesia Symptom Improvement With Measurement-Based CareJoseph P McEvoy
The Journal of Clinical Psychiatry|March 6, 2018
Evidence-Based Strategies for Managing Tardive DyskinesiaJoseph P McEvoy
Behavioral Healthcare|June 1, 2007
The importance of early treatment of schizophreniaJoseph P McEvoy
The Journal of Clinical Psychiatry|July 11, 2006
Risks versus benefits of different types of long-acting injectable antipsychoticsJoseph P McEvoy
Pageof 15